Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martha A Maloneyhuss

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Journal of Feline Medicine and Surgery|April 18, 2019
Efficacy and toxicity of mustargen, vincristine, procarbazine and prednisone (MOPP) for the treatment of relapsed or resistant lymphoma in catsMartha A MaloneyHuss, Glenna E Mauldin, Dorothy C Brown, et al.
Plos One|December 1, 2017
Actionable mutations in canine hemangiosarcomaGuannan Wang, Ming Wu, Martha A Maloneyhuss, et al.
Oncoimmunology|February 1, 2020
Establishing a model system for evaluating CAR T cell therapy using dogs with spontaneous diffuse large B cell lymphomaM Kazim Panjwani, Matthew J Atherton, Martha A MaloneyHuss, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Journal of Feline Medicine and Surgery|April 18, 2019
Efficacy and toxicity of mustargen, vincristine, procarbazine and prednisone (MOPP) for the treatment of relapsed or resistant lymphoma in catsMartha A MaloneyHuss, Glenna E Mauldin, Dorothy C Brown, et al.
Plos One|December 1, 2017
Actionable mutations in canine hemangiosarcomaGuannan Wang, Ming Wu, Martha A Maloneyhuss, et al.
Oncoimmunology|February 1, 2020
Establishing a model system for evaluating CAR T cell therapy using dogs with spontaneous diffuse large B cell lymphomaM Kazim Panjwani, Matthew J Atherton, Martha A MaloneyHuss, et al.
Pageof 1